Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher Begleiter

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Journal of Oncology|March 15, 2002
Lack of NQO1 induction in human tumor cells is not due to changes in the promoter region of the geneAsher Begleiter, Laurie Lange
Methods in Enzymology|March 30, 2004
Induction of NQO1 in cancer cellsAsher Begleiter, Jeanne Fourie
Free Radical Research|October 4, 2006
The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cellsBrian B Hasinoff, Asher Begleiter
Cancer Chemotherapy and Pharmacology|January 27, 2007
Role of NADPH cytochrome P450 reductase in activation of RH1Asher Begleiter, Marsha K Leith, Daywin Patel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 20, 2003
Induction of NAD(P)H quinone: oxidoreductase1 inhibits carcinogen-induced aberrant crypt foci in colons of Sprague-Dawley ratsAsher Begleiter, Kosala Sivananthan, Thomas J Curphey, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|January 9, 2009
Delayed sodium thiosulphate administration reduces cisplatin efficacy on mouse EMT6 tumour cells in vitroMay-Sann Yee, Brian W Blakley, Asher Begleiter, et al.
Leukemia Research|August 5, 2008
Investigation of an NQO1 polymorphism as a possible risk and prognostic factor for chronic lymphocytic leukemiaAsher Begleiter, Donna Hewitt, Spencer B Gibson, et al.
Cancer Chemotherapy and Pharmacology|May 7, 2005
Effect of NQO1 induction on the antitumor activity of RH1 in human tumors in vitro and in vivoTyler Digby, Marsha K Leith, James A Thliveris, et al.
The Journal of Otolaryngology|December 14, 2005
Effect of sodium thiosulphate and cis-diamminedichloroplatinum on FADU tumour cells in nude miceNorbert R Viallet, Brian W Blakley, Asher Begleiter, et al.
The Journal of Otolaryngology|March 11, 2006
Sodium thiosulphate impairs the cytotoxic effects of cisplatin on FADU cells in cultureNorbert R Viallet, Brian B Blakley, Asher Begleiter, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Oncology|March 15, 2002
Lack of NQO1 induction in human tumor cells is not due to changes in the promoter region of the geneAsher Begleiter, Laurie Lange
Methods in Enzymology|March 30, 2004
Induction of NQO1 in cancer cellsAsher Begleiter, Jeanne Fourie
Free Radical Research|October 4, 2006
The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cellsBrian B Hasinoff, Asher Begleiter
Cancer Chemotherapy and Pharmacology|January 27, 2007
Role of NADPH cytochrome P450 reductase in activation of RH1Asher Begleiter, Marsha K Leith, Daywin Patel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 20, 2003
Induction of NAD(P)H quinone: oxidoreductase1 inhibits carcinogen-induced aberrant crypt foci in colons of Sprague-Dawley ratsAsher Begleiter, Kosala Sivananthan, Thomas J Curphey, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|January 9, 2009
Delayed sodium thiosulphate administration reduces cisplatin efficacy on mouse EMT6 tumour cells in vitroMay-Sann Yee, Brian W Blakley, Asher Begleiter, et al.
Leukemia Research|August 5, 2008
Investigation of an NQO1 polymorphism as a possible risk and prognostic factor for chronic lymphocytic leukemiaAsher Begleiter, Donna Hewitt, Spencer B Gibson, et al.
Cancer Chemotherapy and Pharmacology|May 7, 2005
Effect of NQO1 induction on the antitumor activity of RH1 in human tumors in vitro and in vivoTyler Digby, Marsha K Leith, James A Thliveris, et al.
The Journal of Otolaryngology|December 14, 2005
Effect of sodium thiosulphate and cis-diamminedichloroplatinum on FADU tumour cells in nude miceNorbert R Viallet, Brian W Blakley, Asher Begleiter, et al.
The Journal of Otolaryngology|March 11, 2006
Sodium thiosulphate impairs the cytotoxic effects of cisplatin on FADU cells in cultureNorbert R Viallet, Brian B Blakley, Asher Begleiter, et al.
Pageof 2